129 related articles for article (PubMed ID: 31014136)
21. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
22. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.
Chung R; Lai R; Wei P; Lee J; Hanson J; Belch AR; Turner AR; Reiman T
Blood; 2007 Aug; 110(4):1278-82. PubMed ID: 17475910
[TBL] [Abstract][Full Text] [Related]
23. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
[TBL] [Abstract][Full Text] [Related]
24. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.
Yao Z; Deng L; Xu-Monette ZY; Manyam GC; Jain P; Tzankov A; Visco C; Bhagat G; Wang J; Dybkaer K; Tam W; Hsi ED; van Krieken JH; Ponzoni M; Ferreri AJM; Møller MB; Winter JN; Piris MA; Fayad L; Liu Y; Song Y; Orlowski RZ; Kantarjian H; Medeiros LJ; Li Y; Cortes J; Young KH
Leukemia; 2018 Feb; 32(2):353-363. PubMed ID: 28745330
[TBL] [Abstract][Full Text] [Related]
25. Retrospective Analysis of a New Prognostic Score for Diffuse Large B-Cell Lymphoma Based on Interim Positron Emission Tomography-Computed Tomography.
Liu T; Chen L; Pan J; Pan L; Hu J; Ji Z
Acta Haematol; 2018; 139(3):148-157. PubMed ID: 29550822
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma.
Hantaweepant C; Chinthammitr Y; Khuhapinant A; Sukpanichnant S
J Med Assoc Thai; 2016 Mar; 99(3):262-9. PubMed ID: 27276736
[TBL] [Abstract][Full Text] [Related]
27. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
28. A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography.
Iioka F; Honjo G; Misaki T; Toda Y; Izumi K; Kamoda Y; Nagai Y; Akasaka T; Kitamura K; Nakagwa M; Fukutsuka K; Okumura A; Ohno H
Leuk Lymphoma; 2016 Nov; 57(11):2593-602. PubMed ID: 26984373
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
[TBL] [Abstract][Full Text] [Related]
30. Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma.
Wang W; Li Y; Rivera Rivera X; Zhao L; Mei D; Hu W; Jiang B
BMC Cancer; 2021 Sep; 21(1):1011. PubMed ID: 34503477
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
32. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).
Talaulikar D; Shadbolt B; Dahlstrom JE; McDonald A
J Hematol Oncol; 2009 Nov; 2():49. PubMed ID: 19930611
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
[TBL] [Abstract][Full Text] [Related]
34. High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy.
Song MK; Chung JS; Lee JJ; Yang DH; Kim IS; Shin DH; Shin HJ
Int J Hematol; 2015 Feb; 101(2):140-7. PubMed ID: 25504496
[TBL] [Abstract][Full Text] [Related]
35. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
36. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
37. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
Yang Y; Wang L; Ma Y; Han T; Huang M
Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
[TBL] [Abstract][Full Text] [Related]
38. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
40. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.
Nakayama S; Matsuda M; Adachi T; Sueda S; Ohashi Y; Awaji S; Hashimoto S; Matsumura I
Platelets; 2019; 30(5):637-645. PubMed ID: 30047815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
